HUP0401269A3 - Process for the production of amorphous form of clopidogrel hydrogen sulfate - Google Patents
Process for the production of amorphous form of clopidogrel hydrogen sulfateInfo
- Publication number
- HUP0401269A3 HUP0401269A3 HU0401269A HUP0401269A HUP0401269A3 HU P0401269 A3 HUP0401269 A3 HU P0401269A3 HU 0401269 A HU0401269 A HU 0401269A HU P0401269 A HUP0401269 A HU P0401269A HU P0401269 A3 HUP0401269 A3 HU P0401269A3
- Authority
- HU
- Hungary
- Prior art keywords
- production
- amorphous form
- hydrogen sulfate
- clopidogrel hydrogen
- clopidogrel
- Prior art date
Links
- 229950010477 clopidogrel hydrogen sulphate Drugs 0.000 title 1
- FDEODCTUSIWGLK-UHFFFAOYSA-N hydrogen sulfate;hydron;methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)acetate Chemical compound OS(O)(=O)=O.C1CC=2SC=CC=2CN1C(C(=O)OC)C1=CC=CC=C1Cl FDEODCTUSIWGLK-UHFFFAOYSA-N 0.000 title 1
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0401269A HU226565B1 (en) | 2004-06-23 | 2004-06-23 | Process for the production of the amorphous form of clopidogrel hydrogen sulfate |
US10/562,978 US7396931B2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
CA002530446A CA2530446A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
JP2006516496A JP2007516166A (en) | 2003-07-02 | 2004-06-30 | Preparation of amorphous form of platelet aggregation inhibitor |
PCT/HU2004/000069 WO2005003138A2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
EP04743728A EP1648903A2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
SK5011-2006A SK50112006A3 (en) | 2003-07-02 | 2004-06-30 | Process for preparation of amorphous form of platelet aggregation inhibitor drug |
EA200600137A EA200600137A1 (en) | 2003-07-02 | 2004-06-30 | Method for producing amorphous form of an inhibitor of platelet aggregation |
KR1020067000040A KR20060026121A (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
PL378711A PL378711A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
CZ20060060A CZ200660A3 (en) | 2003-07-02 | 2006-01-27 | Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
BG109428A BG109428A (en) | 2003-07-02 | 2006-02-02 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0401269A HU226565B1 (en) | 2004-06-23 | 2004-06-23 | Process for the production of the amorphous form of clopidogrel hydrogen sulfate |
Publications (4)
Publication Number | Publication Date |
---|---|
HU0401269D0 HU0401269D0 (en) | 2004-09-28 |
HUP0401269A2 HUP0401269A2 (en) | 2005-02-28 |
HUP0401269A3 true HUP0401269A3 (en) | 2005-09-28 |
HU226565B1 HU226565B1 (en) | 2009-04-28 |
Family
ID=89985324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0401269A HU226565B1 (en) | 2003-07-02 | 2004-06-23 | Process for the production of the amorphous form of clopidogrel hydrogen sulfate |
Country Status (1)
Country | Link |
---|---|
HU (1) | HU226565B1 (en) |
-
2004
- 2004-06-23 HU HU0401269A patent/HU226565B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HU0401269D0 (en) | 2004-09-28 |
HU226565B1 (en) | 2009-04-28 |
HUP0401269A2 (en) | 2005-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1740593T3 (en) | Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i | |
IL180861A0 (en) | Crystalline imatinib base and production process therefor | |
SI2003136T1 (en) | Process for producing high-purity prasugrel hydrochloride | |
SI1727795T1 (en) | Process for the production of atorvastatin calcium in amorphous form | |
ZA200809118B (en) | Process for hydrogen production | |
HK1119152A1 (en) | Process for producing nanocrystalline | |
EP1861408A4 (en) | Process for the production of hydrochlorosilanes | |
EP1874948A4 (en) | PROCESS FOR THE PRODUCTION OF y-GLUTAMYLCYSTEINE | |
EG24330A (en) | Process for production of precipitated silica fromolivine | |
EP1783162A4 (en) | Process for production of submicrohoneycomb structures | |
SG120243A1 (en) | Hydrogen production process | |
EP1944308A4 (en) | Process for production of ortho-metallized 1:3 complex of iridium with homoligand | |
PL382055A1 (en) | Production method of crystalline form of clopidogrel 1 hydrogen sulphate | |
IL189101A0 (en) | Novel processes for the production of amorphous rabeprazole sodium | |
IL187155A0 (en) | Process for production of 4-biphenylazetidin-2-ones | |
IL185722A0 (en) | Process for the production of methylcobalamin | |
HK1105968A1 (en) | Process for production of 3-alkenylcephem compounds 3- | |
EP1773755A4 (en) | Process for the production of polyisocyanates | |
PL1912961T3 (en) | Process of producing bepromoline | |
ZA200710066B (en) | Process for production of 4-biphenylylazetidin-2-ones | |
EP1889824A4 (en) | Process for production of styrene | |
IL180498A0 (en) | Process for production of steroids | |
EP2114957A4 (en) | Process for preparation of crystalline clopidogrel hydrogen sulphate form i | |
HUP0600194A2 (en) | Process for producing the polymorphic i form of (s)-(+)-methyl-(2-chlorophenyl)-(6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetate hydrogen sulfate | |
IL180345A0 (en) | Improved process for the manufacture of mirtazapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC9A | Change of name, address |
Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |